RED HOT Contributors


Roche doubles down on diabetes, even with reimbursement cuts


diabetes, diabetics, blocks

While the likes of Johnson & Johnson bow out of the diabetes business, Roche, on the other hand, is leveraging digital tools to lower costs, while attempting to reach the largest volume of patients.


We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast